Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-09 to 2024-12-19
Current total value of award: $45.75
Description: 8511065004!MIDAZOLAM HYDROCHLO